Basal cell carcinomas in organ transplant recipients versus the general population: clinicopathologic study.

Publication Year: 2022

DOI:
10.1007/s00403-022-02403-6

PMCID:
PMC10085887

PMID:
36283992

Journal Information

Full Title: Arch Dermatol Res

Abbreviation: Arch Dermatol Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Dermatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestHPS is a shareholder of MoleMap NZ Limited and e-derm consult GmbH, and undertakes regular teledermatological reporting for both companies. HPS is a Medical Consultant for Canfield Scientific Inc, MoleMap Australia Pty Ltd, Blaze Bioscience Inc, Revenio Research Oy and a Medical Advisor for First Derm. All other authors state no conflicts of interest. Ethical approvalProvided. Conflict of interest HPS is a shareholder of MoleMap NZ Limited and e-derm consult GmbH, and undertakes regular teledermatological reporting for both companies. HPS is a Medical Consultant for Canfield Scientific Inc, MoleMap Australia Pty Ltd, Blaze Bioscience Inc, Revenio Research Oy and a Medical Advisor for First Derm. All other authors state no conflicts of interest."

Evidence found in paper:

"Funding Supported by the National Health and Medical Research Council (NHMRC) of Australia (grants 552429 and 1073898) who had no involvement in any aspect of study design, conduct or writing of manuscript. DW was supported by a Research Fellowship from the NHMRC."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025